BeOne Medicines's market cap is currently $42.56B. The company's EPS TTM is $0.91; its P/E ratio is ―; BeOne Medicines is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $0.80. See an overview of income statement, balance sheet, and cash flow financials.
